Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

Grade Last Price % Change Price Change
D 0.19 -43.10% -0.14
TNXP closed down 43.1 percent on Thursday, March 28, 2024, on 13.21 times normal volume. It ran into resistance at its 50 day moving average. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
20 DMA Resistance about 16 hours ago
2x Volume Pace about 16 hours ago
1.5x Volume Pace about 16 hours ago
3x Volume Pace about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman

Is TNXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.0
52 Week Low 0.167
Average Volume 1,655,556
200-Day Moving Average 0.73
50-Day Moving Average 0.34
20-Day Moving Average 0.34
10-Day Moving Average 0.32
Average True Range 0.04
RSI (14) 21.88
ADX 16.71
+DI 9.17
-DI 39.47
Chandelier Exit (Long, 3 ATRs) 0.27
Chandelier Exit (Short, 3 ATRs) 0.29
Upper Bollinger Bands 0.42
Lower Bollinger Band 0.26
Percent B (%b) -0.47
BandWidth 46.64
MACD Line -0.02
MACD Signal Line -0.01
MACD Histogram -0.0113
Fundamentals Value
Market Cap 10.9 Million
Num Shares 58.6 Million
EPS -9.26
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 4.85
Price-to-Book 0.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.45
Resistance 3 (R3) 0.47 0.41 0.41
Resistance 2 (R2) 0.41 0.34 0.40 0.39
Resistance 1 (R1) 0.30 0.30 0.27 0.27 0.38
Pivot Point 0.23 0.23 0.22 0.22 0.23
Support 1 (S1) 0.12 0.16 0.09 0.10 -0.01
Support 2 (S2) 0.06 0.12 0.04 -0.02
Support 3 (S3) -0.06 0.06 -0.04
Support 4 (S4) -0.08